Sunday, February 19, 2012 4:17:57 PM
Down and dirty lowtrade on ATRN...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72291745
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72298318
http://stockcharts.com/h-sc/ui?s=ATRN&p=D&yr=0&mn=2&dy=0&id=p02045486315
Atrinsic, Inc. Trades Feb. 17th 2012 - Buys 14,347,565 / Sells 16,409,804
http://ih.advfn.com/p.php?pid=trades&symbol=USOTC%3AATRN
Est. 2,062,239 shares sold at a average .30 = $618,671.
As long the buys out number the sells, then I say ATRN will continue to rocket... So those day traders better buy more then they sell... If possible!
Go ATRN
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72291745
Because the darkside, which caused the run, has no more shares for sale during runs. The volume now is being shifted, not sold.
From now on, it's pro day traders and M&Ms manipulating retail up and down during the day, creating volume with daily reversals.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72298318
http://stockcharts.com/h-sc/ui?s=ATRN&p=D&yr=0&mn=2&dy=0&id=p02045486315
Atrinsic, Inc. Trades Feb. 17th 2012 - Buys 14,347,565 / Sells 16,409,804
http://ih.advfn.com/p.php?pid=trades&symbol=USOTC%3AATRN
Est. 2,062,239 shares sold at a average .30 = $618,671.
As long the buys out number the sells, then I say ATRN will continue to rocket... So those day traders better buy more then they sell... If possible!
Go ATRN
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
